Table 2 Elevation of CA 19-9 in benign hepatic diseases. L/C, liver cirrhosis; T-bil, total bilirubine; AST, aspartate transferase; ALT, alanine transferase.
From: Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases
Diagnosis | No. of subjects | CA 19-9 (U/mL) Median (Range) | Median of T- bil (mg/dL) | Median of AST (U/mL) | Median of ALT (U/mL) |
|---|---|---|---|---|---|
Alcoholic L/C | 16 | 129.9 (108.2-512.0) | 4.1 | 135.0 | 59.0 |
Alcoholic hepatitis | 13 | 150.7 (80.6-366.8) | 4.7 | 209.0 | 132.0 |
Drug-induced hepatitis | 12 | 160.8 (93.9-688.4) | 9.7 | 642.0 | 534.5 |
Acute hepatitis | 9 | 129.0 (81.8-705.8) | 7.7 | 746.0 | 811.0 |
Chronic hepatitis B | 9 | 122.6 (105.0-493.0) | 1.6 | 198.5 | 312.0 |
Autoimmune hepatitis | 3 | 403.0 (81.2-645.0) | 7.1 | 912.0 | 668.0 |
Liver cyst | 1 | 460.2 |
